Jasper Therapeutics, Inc. (JSPR) has 16 open-market insider trades by 12 insiders since 2022. The most active filer is Thomas G. Wiggans, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TC Group, LLC | 10% Owner | — | 1 | $9.4M | 2023-01-27 |
| Balaji Venkataraman | 10% Owner | — | 1 | $4.5M | 2024-02-08 |
| Qiming U.S. Healthcare GP II, LLC | 10% Owner | — | 1 | $4.0M | 2023-01-27 |
| Abingworth LLP | 10% Owner | — | 1 | $2.5M | 2024-02-08 |
| ROCHE Finance Ltd. via Mitchell Mutz | 10% Owner | — | 1 | $142K | 2023-01-25 |
| Thomas G. Wiggans | Dir | — | 4 | $131K | 2025-09-22 |
| Ron Martell | CEOPres | — | 1 | $100K | 2025-09-22 |
| Judith Anne Shizuru | Dir | — | 1 | $100K | 2025-09-22 |
| William Lis | Dir | — | 2 | $64K | 2023-10-13 |
| Svetlana Lucas | Dir | — | 1 | $49K | 2025-09-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Judith Anne Shizuru | Director | Buy | $100K | 2025-09-22 |
| Svetlana Lucas | Director | Buy | $49K | 2025-09-22 |
| Jeetinder Singh Mahal | COO | Sell | $20K | 2024-12-12 |
| Jeetinder Singh Mahal | COO | Sell | $19K | 2024-09-12 |
| Jeetinder Singh Mahal | COO | Sell | $22K | 2024-06-12 |
| Jeetinder Singh Mahal | COO | Sell | $24K | 2024-03-12 |
Companies that share insiders with JSPR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Balaji Venkataraman | 10% Owner | Buy | $4.5M | 2024-02-08 |
| Abingworth LLP | 10% Owner | Buy | $2.5M | 2024-02-08 |
| Thomas G. Wiggans | Director | Buy | $7K | 2023-11-28 |
| Thomas G. Wiggans | Director | Buy | $6K | 2023-11-21 |
| Thomas G. Wiggans | Director | Buy | $18K | 2023-11-16 |
| William Lis | Director | Sell | $7K | 2023-10-13 |
| Jeetinder Singh Mahal | — | Sell | $15K | 2023-06-13 |
| Anna Louise French | Director | Sell | $10K | 2023-04-14 |
| William Lis | Director | Sell | $12K | 2023-04-13 |